Imipenem

A beta-lactam (carbapenem) antibiotic.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Other treatment

Drug status

Used to treat other disease

2
Supporting references
0
Contradictory references
2
AI-suggested references
0
Clinical trials

General information

Imipenem is a beta-lactam antibiotic of the carbapenem subgroup. It is used intravenously (ChEBI).

Imipenem on DrugBank
Imipenem on PubChem
Imipenem on Wikipedia


Marketed as

In a fixed dose with Cilastatin sodium: IMIPENEM AND CILASTATIN; PRIMAXIN

 

Structure image - Imipenem

C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O


Supporting references

Link Tested on Impact factor Notes Publication date
Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents
Small molecule Animal model
Male C57BL/6 J mice; murine peritoneal macrophages; human peripheral blood mononuclear cells 4.55

Alleviate acute lung injury in mice. Inhibit LPS-stimulated TNF-α and IL-10 in models based on murine peritoneal macrophages or human peipheral blood mononuclear cells.

Aug/23/2020
In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations
Spike protein Small molecule In silico
in silico 6.28

Predicted to bind the

Sep/22/2020

AI-suggested references